HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

IMMUNEONCO-B

3.205

-0.135-4.04%

Volume:692.80K

Turnover:2.23M

Market Cap:1.37B

PE:-5.17

High:3.310

Open:3.305

Low:3.145

Close:3.340

52wk High:16.800

52wk Low:2.800

Shares:429.00M

HK Float Shares:418.00M

Volume Ratio:1.97

T/O Rate:0.17%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.620

ROE:-40.11%

ROA:-14.74%

PB:1.88

PE(LYR):-5.17

PS:7.97

Loading ...

Overview Company News Filings

IMMUNEONCO-B (01541) Completes Share Buyback of 55,200 Shares on September 11

Immuneonco Biopharma Files HKEX Next-Day Disclosure Return on Share Buyback, Cancellation

ImmuneOnco Files HKEX Next-Day Disclosure Return on Share Repurchase for Treasury Shares

ImmuneOnco Reports HKD 0.16 Million Share Buy-back; Treasury Shares Rise to 2.07 Million

Bulletin Express

ImmuneOnco Biopharma Files HKEX Next-Day Disclosure Return on Share Repurchase

ImmuneOnco Nominates Dr. Liou Hsiou-Chi as Independent Non-Executive Director

IMMUNEONCO-B Advances Phase II Trial for First-Line Advanced Liver Cancer Therapy With Initial Patient Dosing Completed

ImmuneOnco Initiates Phase II Trial: First Patient Dosed with IMM2510 + IMM27M for Front-Line Advanced HCC Therapy

Bulletin Express

ImmuneOnco Doses First Patient in Phase II Trial of Imm2510-Imm27m Combo for First-Line Advanced Liver Cancer

IMMUNEONCO-B Surges Over 10% in Afternoon Trade on Strong First-Half Revenue

Hong Kong Stock Alert | IMMUNEONCO-B (01541) Surges Nearly 12% as Robust Cash Reserves and Major Clinical Milestones Drive Sentiment

IMMUNEONCO-B Reports Interim Results with RMB 25.4 Million Revenue and Key Clinical Trial Milestones

ImmuneOnco FY26 Interim Revenue Falls 33.2% to RMB 25.4 Million; R&D Expenses Drop 7.9% to RMB 154.8 Million

ImmuneOnco reaches two clinical milestones for IMC-003: first PAH patient dosed and Phase I enrolment completed

Bulletin Express

IMMUNEONCO-B (01541) Achieves Two Key Clinical Milestones in IMC-003 Development, Including First PAH Patient Dosed

ImmuneOnco Says First PAH Patient Dosed in Phase Ib/IIa Trial of IMC-003

ImmuneOnco secures FDA IND clearance for Phase Ib/II study of dual-targeting antibody IMM0306 in systemic lupus erythematosus

Bulletin Express

ImmuneOnco Wins FDA IND Clearance for Imm0306 Lupus Phase Ib/II Trial

ImmuneOnco Biopharmaceuticals (Shanghai) - Receives FDA Approval for Ind Application of Imm0306 for Phase Ib/Ii Sle Trial

THOMSON REUTERS

ImmuneOnco to Convene 26 Aug 2026 Board Meeting for 1H26 Results and Interim Dividend Deliberation

Bulletin Express

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/01541/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"01541","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01541\",,,,,undefined,":{"symbol":"01541","market":"HK","secType":"STK","nameCN":"IMMUNEONCO-B","latestPrice":3.205,"timestamp":1789114133980,"preClose":3.34,"halted":0,"volume":692800,"delay":0,"changeRate":-0.040419161676646644,"floatShares":418000000,"shares":429000000,"eps":-0.6196134663341646,"marketStatus":"Not Yet Opened","change":-0.135,"latestTime":"09-11 16:08:53","open":3.305,"high":3.31,"low":3.145,"amount":2228134,"amplitude":0.049401,"askPrice":3.275,"askSize":2200,"bidPrice":3.205,"bidSize":3600,"shortable":0,"etf":0,"ttmEps":-0.6339581026208065,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789349400000},"marketStatusCode":0,"adr":0,"listingDate":1693843200000,"exchange":"SEHK","adjPreClose":3.34,"openAndCloseTimeList":[[1789090200000,1789099200000],[1789102800000,1789113600000]],"volumeRatio":1.9668407910960972,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01541\",,,,,undefined,":{"symbol":"01541","floatShares":418000000,"roa":"-14.74%","roe":"-40.11%","lyrEps":-0.619613,"volumeRatio":1.9668407910960972,"shares":429000000,"dividePrice":0,"high":3.31,"amplitude":0.049401,"preClose":3.34,"low":3.145,"week52Low":2.8,"pbRate":"1.88","psRate":"7.97","week52High":16.8,"institutionHeld":0,"latestPrice":3.205,"committee":0.241379,"eps":-0.6196134663341646,"divideRate":0,"volume":692800,"delay":0,"ttmEps":-0.6339581026208065,"open":3.305,"prevYearClose":5.83,"prevWeekClose":3.205,"prevMonthClose":3.71,"prevQuarterClose":3.87,"fiveDayClose":3.4,"twentyDayClose":3.9,"sixtyDayClose":3.56},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01541\",params:#limit:5,,,undefined,":[{"date":"2026-08-26","symbol":"01541","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787707800000,"name":null,"time":"","dateTimestamp":1787673600000,"actualEps":null},{"date":"2026-03-25","symbol":"01541","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774402200000,"name":null,"time":"","dateTimestamp":1774368000000,"actualEps":null},{"date":"2025-08-26","symbol":"01541","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756171800000,"name":null,"time":"","dateTimestamp":1756137600000,"actualEps":null},{"date":"2025-03-25","symbol":"01541","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742866200000,"name":null,"time":"Post-Mkt","dateTimestamp":1742832000000,"actualEps":null},{"market":"HK","date":"2024-08-26","symbol":"01541","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1724601600000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01541\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01541\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1697558400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01541\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01541","date":"2026-09-11","current":-5.055539,"percent":0.926075,"low":-30.003263,"twenty":-16.193559,"median":-9.001174,"eighty":-5.799572,"high":-2.993766,"avg":-11.794806,"sd":6.994649,"marketCap":1377061886},"quantilePoints":[{"date":"2023-08-31","current":-17.746094,"twenty":-17.746094,"median":-17.746094,"eighty":-17.746094,"marketCap":6942262047},{"date":"2023-09-08","current":-19.116691,"twenty":-19.083294,"median":-18.655615,"eighty":-17.801139,"marketCap":7390149921},{"date":"2023-09-15","current":-24.765877,"twenty":-24.765877,"median":-19.116691,"eighty":-18.557812,"marketCap":9648251285},{"date":"2023-09-22","current":-25.548224,"twenty":-25.200205,"median":-24.360534,"eighty":-18.753419,"marketCap":9909519212},{"date":"2023-09-29","current":-29.804324,"twenty":-26.447668,"median":-24.870232,"eighty":-19.083294,"marketCap":11580180660},{"date":"2023-10-06","current":-24.76052,"twenty":-26.458287,"median":-24.870232,"eighty":-19.110012,"marketCap":9615852761},{"date":"2023-10-13","current":-27.113287,"twenty":-26.458287,"median":-25.206314,"eighty":-22.322253,"marketCap":10513831229},{"date":"2023-10-20","current":-26.768577,"twenty":-26.795293,"median":-25.37532,"eighty":-23.788881,"marketCap":10364168151},{"date":"2023-10-27","current":-28.665306,"twenty":-27.124745,"median":-25.753577,"eighty":-24.00727,"marketCap":11093775656},{"date":"2023-11-03","current":-26.275244,"twenty":-27.500238,"median":-26.158488,"eighty":-24.473108,"marketCap":10195797188},{"date":"2023-11-10","current":-26.039628,"twenty":-27.37617,"median":-26.041732,"eighty":-24.763734,"marketCap":10102257765},{"date":"2023-11-17","current":-26.714897,"twenty":-27.225983,"median":-26.171076,"eighty":-24.792429,"marketCap":10457707575},{"date":"2023-11-24","current":-27.539565,"twenty":-27.37617,"median":-26.271304,"eighty":-24.846191,"marketCap":10869281039},{"date":"2023-12-01","current":-28.464343,"twenty":-27.564693,"median":-26.306056,"eighty":-24.874164,"marketCap":11280854504},{"date":"2023-12-08","current":-27.67933,"twenty":-27.70336,"median":-26.447668,"eighty":-25.070837,"marketCap":10925404694},{"date":"2023-12-15","current":-27.708906,"twenty":-27.817253,"median":-26.526325,"eighty":-25.207536,"marketCap":11000236233},{"date":"2023-12-22","current":-27.916049,"twenty":-27.937914,"median":-26.714897,"eighty":-25.244891,"marketCap":11075067772},{"date":"2023-12-29","current":-28.049426,"twenty":-27.986303,"median":-26.835368,"eighty":-25.288293,"marketCap":11187315080},{"date":"2024-01-05","current":-23.146888,"twenty":-27.970711,"median":-26.68937,"eighty":-25.200205,"marketCap":9166863527},{"date":"2024-01-12","current":-26.439512,"twenty":-27.935571,"median":-26.500765,"eighty":-25.200205,"marketCap":10476415460},{"date":"2024-01-19","current":-25.435754,"twenty":-27.916049,"median":-26.490281,"eighty":-25.212424,"marketCap":10064841995},{"date":"2024-01-26","current":-23.636611,"twenty":-27.83997,"median":-26.442842,"eighty":-24.972615,"marketCap":9316526605},{"date":"2024-02-02","current":-21.195554,"twenty":-27.817533,"median":-26.372788,"eighty":-24.783518,"marketCap":8343716598},{"date":"2024-02-09","current":-18.727145,"twenty":-27.802108,"median":-26.275244,"eighty":-24.041989,"marketCap":7408322361},{"date":"2024-02-16","current":-17.739662,"twenty":-27.801452,"median":-26.252628,"eighty":-23.794995,"marketCap":7019198358},{"date":"2024-02-23","current":-22.387155,"twenty":-27.764049,"median":-26.165159,"eighty":-23.13759,"marketCap":8811413717},{"date":"2024-03-01","current":-17.708555,"twenty":-27.735275,"median":-26.04068,"eighty":-22.460898,"marketCap":6974299434},{"date":"2024-03-08","current":-19.229551,"twenty":-27.718352,"median":-26.025076,"eighty":-21.141323,"marketCap":7576693323},{"date":"2024-03-15","current":-16.157629,"twenty":-27.69116,"median":-25.695795,"eighty":-19.998834,"marketCap":6360680815},{"date":"2024-03-22","current":-15.411367,"twenty":-27.66021,"median":-25.548224,"eighty":-19.057216,"marketCap":6061354659},{"date":"2024-03-28","current":-14.696214,"twenty":-27.629432,"median":-25.408294,"eighty":-18.737655,"marketCap":6038905197},{"date":"2024-04-05","current":-13.011166,"twenty":-27.602384,"median":-25.364375,"eighty":-18.557812,"marketCap":5342971884},{"date":"2024-04-12","current":-13.094845,"twenty":-27.539565,"median":-25.225009,"eighty":-18.239836,"marketCap":5380387654},{"date":"2024-04-19","current":-13.014894,"twenty":-27.51439,"median":-25.154554,"eighty":-17.708555,"marketCap":5342971884},{"date":"2024-04-26","current":-13.779237,"twenty":-27.443648,"median":-24.972615,"eighty":-16.602696,"marketCap":5649781194},{"date":"2024-05-03","current":-12.839078,"twenty":-27.434442,"median":-24.870232,"eighty":-16.184677,"marketCap":5260657191},{"date":"2024-05-10","current":-13.282389,"twenty":-27.357513,"median":-24.774698,"eighty":-14.702373,"marketCap":5455219193},{"date":"2024-05-17","current":-13.228926,"twenty":-27.225983,"median":-24.581805,"eighty":-14.243189,"marketCap":5425286577},{"date":"2024-05-24","current":-13.350651,"twenty":-27.145452,"median":-23.955191,"eighty":-13.966896,"marketCap":5462702347},{"date":"2024-05-31","current":-13.410156,"twenty":-27.124745,"median":-23.750163,"eighty":-13.747349,"marketCap":5492634962},{"date":"2024-06-07","current":-14.158514,"twenty":-27.039336,"median":-23.288627,"eighty":-13.645876,"marketCap":5791961118},{"date":"2024-06-14","current":-13.347574,"twenty":-26.971042,"median":-23.123643,"eighty":-13.527845,"marketCap":5455219193},{"date":"2024-06-21","current":-13.283836,"twenty":-26.926395,"median":-22.448608,"eighty":-13.452996,"marketCap":5417803423},{"date":"2024-06-28","current":-12.683619,"twenty":-26.848726,"median":-21.974147,"eighty":-13.40419,"marketCap":5170859344},{"date":"2024-07-05","current":-11.291057,"twenty":-26.759122,"median":-21.059976,"eighty":-13.359292,"marketCap":4602139648},{"date":"2024-07-12","current":-12.246119,"twenty":-26.720023,"median":-20.206581,"eighty":-13.323498,"marketCap":4998746805},{"date":"2024-07-19","current":-11.915911,"twenty":-26.704686,"median":-19.229551,"eighty":-13.282563,"marketCap":4864050035},{"date":"2024-07-26","current":-11.780484,"twenty":-26.652155,"median":-19.050696,"eighty":-13.224977,"marketCap":4826634265},{"date":"2024-08-02","current":-13.633124,"twenty":-26.594701,"median":-18.753419,"eighty":-13.20236,"marketCap":5582432809},{"date":"2024-08-09","current":-9.567144,"twenty":-26.54166,"median":-18.630761,"eighty":-13.102374,"marketCap":3943622105},{"date":"2024-08-16","current":-8.483685,"twenty":-26.496571,"median":-18.451463,"eighty":-13.086665,"marketCap":3498374448},{"date":"2024-08-23","current":-8.095604,"twenty":-26.47337,"median":-18.020488,"eighty":-13.035717,"marketCap":3352452947},{"date":"2024-08-30","current":-7.377309,"twenty":-26.446703,"median":-17.739662,"eighty":-12.990136,"marketCap":3034418906},{"date":"2024-09-06","current":-4.227864,"twenty":-26.442176,"median":-17.681919,"eighty":-12.840212,"marketCap":1739833281},{"date":"2024-09-13","current":-4.503325,"twenty":-26.43833,"median":-16.602696,"eighty":-12.741292,"marketCap":1848339013},{"date":"2024-09-20","current":-4.539912,"twenty":-26.433601,"median":-16.202037,"eighty":-12.246119,"marketCap":1874530051},{"date":"2024-09-27","current":-5.476578,"twenty":-26.311976,"median":-15.844451,"eighty":-11.915911,"marketCap":2274878785},{"date":"2024-10-04","current":-6.596451,"twenty":-26.302504,"median":-15.05764,"eighty":-11.832338,"marketCap":2727609596},{"date":"2024-10-10","current":-5.983695,"twenty":-26.285201,"median":-14.496802,"eighty":-11.807116,"marketCap":2458216056},{"date":"2024-10-18","current":-5.191078,"twenty":-26.27288,"median":-14.209972,"eighty":-11.719903,"marketCap":2121474130},{"date":"2024-10-25","current":-7.104995,"twenty":-26.248892,"median":-14.119017,"eighty":-11.287262,"marketCap":2903463713},{"date":"2024-11-01","current":-6.615271,"twenty":-26.199776,"median":-13.881638,"eighty":-9.764235,"marketCap":2705160134},{"date":"2024-11-08","current":-6.847628,"twenty":-26.169892,"median":-13.803075,"eighty":-8.441853,"marketCap":2787474827},{"date":"2024-11-15","current":-7.078843,"twenty":-26.118271,"median":-13.690467,"eighty":-8.248986,"marketCap":2851081635},{"date":"2024-11-22","current":-6.784782,"twenty":-26.059844,"median":-13.633178,"eighty":-7.853303,"marketCap":2731351173},{"date":"2024-11-29","current":-5.682581,"twenty":-26.04047,"median":-13.539989,"eighty":-7.45767,"marketCap":2286103516},{"date":"2024-12-06","current":-5.602773,"twenty":-26.037499,"median":-13.514674,"eighty":-7.358253,"marketCap":2248687746},{"date":"2024-12-13","current":-6.121403,"twenty":-26.029477,"median":-13.45004,"eighty":-7.218028,"marketCap":2451992323},{"date":"2024-12-20","current":-5.137492,"twenty":-25.962318,"median":-13.411134,"eighty":-7.087735,"marketCap":2048757705},{"date":"2024-12-27","current":-4.957491,"twenty":-25.887099,"median":-13.400213,"eighty":-7.078006,"marketCap":1975442320},{"date":"2025-01-03","current":-5.238569,"twenty":-25.753577,"median":-13.368079,"eighty":-6.925822,"marketCap":2089488475},{"date":"2025-01-10","current":-5.002231,"twenty":-25.638014,"median":-13.3526,"eighty":-6.765934,"marketCap":1987661551},{"date":"2025-01-17","current":-5.018682,"twenty":-25.5579,"median":-13.317479,"eighty":-6.665777,"marketCap":1995807705},{"date":"2025-01-24","current":-5.323319,"twenty":-25.548224,"median":-13.283546,"eighty":-6.596451,"marketCap":2130219244},{"date":"2025-01-28","current":-5.224689,"twenty":-25.503236,"median":-13.282823,"eighty":-6.532117,"marketCap":2101707706},{"date":"2025-02-07","current":-5.549725,"twenty":-25.42477,"median":-13.246663,"eighty":-6.254752,"marketCap":2219826937},{"date":"2025-02-14","current":-5.930475,"twenty":-25.395104,"median":-13.220128,"eighty":-6.076947,"marketCap":2366457707},{"date":"2025-02-21","current":-6.375256,"twenty":-25.366564,"median":-13.201126,"eighty":-6.054191,"marketCap":2557892324},{"date":"2025-02-28","current":-5.632443,"twenty":-25.318672,"median":-13.116805,"eighty":-5.974648,"marketCap":2252411553},{"date":"2025-03-07","current":-5.782376,"twenty":-25.249925,"median":-13.099044,"eighty":-5.827424,"marketCap":2321653861},{"date":"2025-03-14","current":-4.421401,"twenty":-25.219975,"median":-13.087912,"eighty":-5.725677,"marketCap":1775861550},{"date":"2025-03-21","current":-4.778207,"twenty":-25.207536,"median":-13.071662,"eighty":-5.66584,"marketCap":1918419243},{"date":"2025-03-28","current":-6.735516,"twenty":-25.163684,"median":-13.026305,"eighty":-5.651503,"marketCap":2276850015},{"date":"2025-04-03","current":-7.956153,"twenty":-25.0977,"median":-13.01303,"eighty":-5.66026,"marketCap":2684157710},{"date":"2025-04-11","current":-6.344288,"twenty":-25.036833,"median":-12.972072,"eighty":-5.68428,"marketCap":2126146167},{"date":"2025-04-17","current":-6.122985,"twenty":-24.972615,"median":-12.844749,"eighty":-5.691075,"marketCap":2056903859},{"date":"2025-04-25","current":-8.576896,"twenty":-24.895951,"median":-12.836736,"eighty":-5.703559,"marketCap":2883738480},{"date":"2025-05-02","current":-7.700417,"twenty":-24.872853,"median":-12.82514,"eighty":-5.710649,"marketCap":2594550017},{"date":"2025-05-09","current":-7.730765,"twenty":-24.846191,"median":-12.683619,"eighty":-5.725677,"marketCap":2623061555},{"date":"2025-05-16","current":-8.311097,"twenty":-24.799485,"median":-12.12195,"eighty":-5.751942,"marketCap":2843007711},{"date":"2025-05-23","current":-11.289802,"twenty":-24.776462,"median":-11.940532,"eighty":-5.771038,"marketCap":3873496179},{"date":"2025-05-30","current":-15.223569,"twenty":-24.763734,"median":-11.970101,"eighty":-5.797425,"marketCap":5246123111},{"date":"2025-06-06","current":-16.623143,"twenty":-24.617548,"median":-12.331836,"eighty":-5.827424,"marketCap":5743038499},{"date":"2025-06-13","current":-15.603079,"twenty":-24.258649,"median":-12.701975,"eighty":-5.862056,"marketCap":5392753881},{"date":"2025-06-20","current":-14.878015,"twenty":-24.00727,"median":-12.82804,"eighty":-5.90109,"marketCap":5132076957},{"date":"2025-06-27","current":-13.023121,"twenty":-23.933348,"median":-12.837907,"eighty":-5.91626,"marketCap":4504823106},{"date":"2025-07-04","current":-14.906416,"twenty":-23.89321,"median":-12.895238,"eighty":-5.935244,"marketCap":5156515418},{"date":"2025-07-11","current":-12.022018,"twenty":-23.818294,"median":-12.972072,"eighty":-5.957179,"marketCap":4154538489},{"date":"2025-07-18","current":-12.975089,"twenty":-23.597552,"median":-12.895238,"eighty":-5.971632,"marketCap":4480384645},{"date":"2025-07-25","current":-12.316929,"twenty":-23.410778,"median":-12.839078,"eighty":-5.984465,"marketCap":4268584643},{"date":"2025-08-01","current":-12.109688,"twenty":-23.260279,"median":-12.895238,"eighty":-5.992729,"marketCap":4170830796},{"date":"2025-08-08","current":-13.046774,"twenty":-23.142239,"median":-12.972072,"eighty":-6.013995,"marketCap":4504823106},{"date":"2025-08-15","current":-15.594562,"twenty":-23.052783,"median":-12.982136,"eighty":-6.023266,"marketCap":5376461574},{"date":"2025-08-22","current":-14.245172,"twenty":-22.717488,"median":-13.011166,"eighty":-6.052989,"marketCap":4895838493},{"date":"2025-08-29","current":-13.416028,"twenty":-22.485479,"median":-13.022379,"eighty":-6.061027,"marketCap":4439653875},{"date":"2025-09-05","current":-17.224047,"twenty":-22.314693,"median":-13.032106,"eighty":-6.075447,"marketCap":5694161576},{"date":"2025-09-12","current":-15.065483,"twenty":-22.014704,"median":-13.063177,"eighty":-6.087386,"marketCap":4989519263},{"date":"2025-09-19","current":-14.903882,"twenty":-21.818428,"median":-13.085834,"eighty":-6.113201,"marketCap":4932496186},{"date":"2025-09-26","current":-13.980202,"twenty":-21.168438,"median":-13.096763,"eighty":-6.121719,"marketCap":4614796184},{"date":"2025-10-03","current":-19.067762,"twenty":-21.059976,"median":-13.099741,"eighty":-6.122985,"marketCap":6309196195},{"date":"2025-10-10","current":-15.483575,"twenty":-20.658991,"median":-13.109708,"eighty":-6.128239,"marketCap":5115784649},{"date":"2025-10-17","current":-12.892469,"twenty":-20.520951,"median":-13.123492,"eighty":-6.17051,"marketCap":4256365412},{"date":"2025-10-24","current":-11.824326,"twenty":-20.411262,"median":-13.104868,"eighty":-6.183537,"marketCap":3905144639},{"date":"2025-10-31","current":-11.96327,"twenty":-20.170656,"median":-13.098863,"eighty":-6.223751,"marketCap":3956925563},{"date":"2025-11-07","current":-10.312858,"twenty":-19.984772,"median":-13.08999,"eighty":-6.257081,"marketCap":3408910790},{"date":"2025-11-14","current":-10.296734,"twenty":-19.520389,"median":-13.071805,"eighty":-6.311268,"marketCap":3413225867},{"date":"2025-11-21","current":-8.92105,"twenty":-19.161835,"median":-13.046774,"eighty":-6.362869,"marketCap":2955827710},{"date":"2025-11-28","current":-9.407815,"twenty":-19.096653,"median":-13.027047,"eighty":-6.414675,"marketCap":3128430788},{"date":"2025-12-05","current":-8.666243,"twenty":-19.073975,"median":-13.014894,"eighty":-6.44644,"marketCap":2886786479},{"date":"2025-12-12","current":-8.404571,"twenty":-19.037964,"median":-12.986335,"eighty":-6.450097,"marketCap":2804800017},{"date":"2025-12-19","current":-8.049417,"twenty":-18.988805,"median":-12.975089,"eighty":-6.476679,"marketCap":2692608016},{"date":"2025-12-24","current":-7.972984,"twenty":-18.926105,"median":-12.9589,"eighty":-6.505915,"marketCap":2675347709},{"date":"2026-01-02","current":-7.788017,"twenty":-18.753419,"median":-12.908879,"eighty":-6.55197,"marketCap":2623566785},{"date":"2026-01-09","current":-8.075331,"twenty":-18.727145,"median":-12.839078,"eighty":-6.58869,"marketCap":2727128632},{"date":"2026-01-16","current":-7.93455,"twenty":-18.70371,"median":-12.833897,"eighty":-6.596451,"marketCap":2688292939},{"date":"2026-01-23","current":-6.093671,"twenty":-18.557812,"median":-12.82514,"eighty":-6.55197,"marketCap":2062606782},{"date":"2026-01-30","current":-5.748685,"twenty":-18.530718,"median":-12.736832,"eighty":-6.440954,"marketCap":1954729858},{"date":"2026-02-06","current":-5.480977,"twenty":-18.467104,"median":-12.547098,"eighty":-6.250095,"marketCap":1868428319},{"date":"2026-02-13","current":-5.764322,"twenty":-18.451463,"median":-12.334661,"eighty":-6.129552,"marketCap":1976305243},{"date":"2026-02-20","current":-5.709616,"twenty":-18.447248,"median":-12.324382,"eighty":-6.122036,"marketCap":1954729858},{"date":"2026-02-27","current":-5.173921,"twenty":-18.36049,"median":-12.246119,"eighty":-6.086335,"marketCap":1790756934},{"date":"2026-03-06","current":-5.567891,"twenty":-18.158064,"median":-12.065853,"eighty":-6.054191,"marketCap":1911579088},{"date":"2026-03-13","current":-6.117869,"twenty":-18.015354,"median":-11.997781,"eighty":-6.054191,"marketCap":2110072628},{"date":"2026-03-20","current":-5.927628,"twenty":-17.916043,"median":-11.941476,"eighty":-6.046952,"marketCap":2036716320},{"date":"2026-03-27","current":-7.775976,"twenty":-17.807771,"median":-11.897801,"eighty":-5.998519,"marketCap":1924524319},{"date":"2026-04-02","current":-8.241979,"twenty":-17.7975,"median":-11.83436,"eighty":-6.013995,"marketCap":2049661551},{"date":"2026-04-10","current":-8.161679,"twenty":-17.786583,"median":-11.824288,"eighty":-6.015601,"marketCap":2045346474},{"date":"2026-04-17","current":-10.223634,"twenty":-17.753464,"median":-11.822864,"eighty":-6.03821,"marketCap":2563155708},{"date":"2026-04-24","current":-8.708527,"twenty":-17.740948,"median":-11.788146,"eighty":-6.050175,"marketCap":2183428936},{"date":"2026-04-30","current":-8.01805,"twenty":-17.720998,"median":-11.771721,"eighty":-6.055393,"marketCap":2010825858},{"date":"2026-05-08","current":-7.201573,"twenty":-17.693999,"median":-11.728007,"eighty":-6.067488,"marketCap":1812332319},{"date":"2026-05-15","current":-6.019771,"twenty":-17.681444,"median":-11.664585,"eighty":-6.067488,"marketCap":1518907086},{"date":"2026-05-22","current":-5.845011,"twenty":-17.559701,"median":-11.603261,"eighty":-6.055393,"marketCap":1471441239},{"date":"2026-05-29","current":-5.00485,"twenty":-17.377503,"median":-11.514742,"eighty":-6.021369,"marketCap":1264317546},{"date":"2026-06-05","current":-5.406956,"twenty":-17.219881,"median":-11.323354,"eighty":-5.987951,"marketCap":1367879393},{"date":"2026-06-12","current":-6.161616,"twenty":-17.185737,"median":-11.281569,"eighty":-5.974648,"marketCap":1557742778},{"date":"2026-06-18","current":-6.148633,"twenty":-17.12503,"median":-11.173523,"eighty":-5.983773,"marketCap":1557742778},{"date":"2026-06-26","current":-6.245478,"twenty":-17.024379,"median":-10.700224,"eighty":-5.984776,"marketCap":1575003086},{"date":"2026-07-03","current":-6.68536,"twenty":-16.923645,"median":-10.487176,"eighty":-5.987546,"marketCap":1687195087},{"date":"2026-07-10","current":-5.923214,"twenty":-16.909148,"median":-10.312858,"eighty":-5.984083,"marketCap":1493016624},{"date":"2026-07-17","current":-5.902209,"twenty":-16.682476,"median":-10.158539,"eighty":-5.968616,"marketCap":1493016624},{"date":"2026-07-24","current":-5.542738,"twenty":-16.623143,"median":-9.958283,"eighty":-5.926348,"marketCap":1402400008},{"date":"2026-07-31","current":-5.106671,"twenty":-16.606785,"median":-9.895629,"eighty":-5.905868,"marketCap":1294523085},{"date":"2026-08-07","current":-5.351615,"twenty":-16.539438,"median":-9.757608,"eighty":-5.872434,"marketCap":1359249239},{"date":"2026-08-14","current":-6.61743,"twenty":-16.502556,"median":-9.567144,"eighty":-5.872434,"marketCap":1682880010},{"date":"2026-08-21","current":-5.73939,"twenty":-16.475236,"median":-9.478992,"eighty":-5.870008,"marketCap":1462811086},{"date":"2026-08-28","current":-5.937689,"twenty":-16.271167,"median":-9.407815,"eighty":-5.870008,"marketCap":1594040436},{"date":"2026-09-04","current":-5.439364,"twenty":-16.205935,"median":-9.267733,"eighty":-5.847482,"marketCap":1460845683},{"date":"2026-09-11","current":-5.120491,"twenty":-16.193559,"median":-9.001174,"eighty":-5.799572,"marketCap":1377061886}],"updateTime":1789330455419},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01541\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1180962518","title":"IMMUNEONCO-B (01541) Completes Share Buyback of 55,200 Shares on September 11","url":"https://stock-news.laohu8.com/highlight/detail?id=1180962518","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180962518?lang=en_us&edition=fundamental","pubTime":"2026-09-11 18:28","pubTimestamp":1789122500,"startTime":"0","endTime":"0","summary":"IMMUNEONCO-B (01541) has announced that on September 11, 2026, the company repurchased 55,200 of its shares for a total consideration of HK$177,600.The buyback transaction was disclosed in an official filing, reflecting the company's ongoing capital management strategy.","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666525732","title":"Immuneonco Biopharma Files HKEX Next-Day Disclosure Return on Share Buyback, Cancellation","url":"https://stock-news.laohu8.com/highlight/detail?id=2666525732","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666525732?lang=en_us&edition=fundamental","pubTime":"2026-09-11 18:26","pubTimestamp":1789122399,"startTime":"0","endTime":"0","summary":"Immuneonco Biopharma files HKEX next-day disclosure return on share buyback, cancellationImmuneonco Biopharmaceuticals filed a next-day disclosure return showing a repurchase of 55,200 H shares on Sep","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nNDL8qrm3p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666562554","title":"ImmuneOnco Files HKEX Next-Day Disclosure Return on Share Repurchase for Treasury Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2666562554","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666562554?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:14","pubTimestamp":1789035243,"startTime":"0","endTime":"0","summary":"ImmuneOnco files HKEX next-day disclosure return on share repurchase for treasury sharesImmuneOnco repurchased 58,000 H shares on Sept. 10 for treasury.Buyback price ranged from HKD 3.35 to HKD 3.44 p","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL6PWdxv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145259717","title":"ImmuneOnco Reports HKD 0.16 Million Share Buy-back; Treasury Shares Rise to 2.07 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1145259717","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145259717?lang=en_us&edition=fundamental","pubTime":"2026-09-04 18:41","pubTimestamp":1788518510,"startTime":"0","endTime":"0","summary":"ImmuneOnco Biopharmaceuticals (Shanghai) Inc. disclosed a new share repurchase on 4 September 2026 under its existing mandate, buying back 44,800 H shares on the Hong Kong Stock Exchange. Key...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664336510","title":"ImmuneOnco Biopharma Files HKEX Next-Day Disclosure Return on Share Repurchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2664336510","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664336510?lang=en_us&edition=fundamental","pubTime":"2026-09-04 18:39","pubTimestamp":1788518380,"startTime":"0","endTime":"0","summary":"ImmuneOnco Biopharma files HKEX next-day disclosure return on share repurchaseImmuneOnco Biopharmaceuticals (Shanghai) filed a next-day disclosure return reporting a 44,800 H-share buyback on Sept. 4.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDLc9gB6h:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662909679","title":"ImmuneOnco Nominates Dr. Liou Hsiou-Chi as Independent Non-Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2662909679","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662909679?lang=en_us&edition=fundamental","pubTime":"2026-08-28 22:01","pubTimestamp":1787925691,"startTime":"0","endTime":"0","summary":"ImmuneOnco nominates Dr. Liou Hsiou-Chi as independent non-executive directorImmuneOnco Biopharmaceuticals (Shanghai) disclosed the planned exit of independent director Zhenping Zhu, effective once a ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL2q61tP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541","LU1989771016.USD","LU0648001328.SGD","LU0053666078.USD","LU0130102774.USD","LU0106831901.USD","LU0130518102.USD","LU1291159041.SGD","LU1883839398.USD","FNCL","LU1280957306.USD","BK4504","LU0640476718.USD","LU0306807586.USD","LU0130103400.USD","LU0234572021.USD","LU0320765489.SGD","KBWB","BK4534","BK4553","VFH","LU0070302665.USD","LU0868494617.USD","LU0980610538.SGD","LU1162221912.USD","BK4588","IE00B1BXHZ80.USD","IE0002270589.USD","IYG","LU0321505868.SGD","LU1366192091.USD","LU1804176565.USD","FTXO","LU0130517989.USD","LU1894683264.USD","LU1201861249.SGD","XLF","TFNS","LU0683600562.USD","LU2133065610.SGD","UYG","LU0098860793.USD","IE00BLSP4452.SGD","BAC","LU0052756011.USD","LU1880398554.USD","IE0001KFT4U8.USD","LU0128525689.USD","IYF","LU0208291251.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195720547","title":"IMMUNEONCO-B Advances Phase II Trial for First-Line Advanced Liver Cancer Therapy With Initial Patient Dosing Completed","url":"https://stock-news.laohu8.com/highlight/detail?id=1195720547","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195720547?lang=en_us&edition=fundamental","pubTime":"2026-08-27 21:24","pubTimestamp":1787837055,"startTime":"0","endTime":"0","summary":"IMMUNEONCO-B (01541) has announced that the Phase II clinical trial evaluating IMM2510 (Peravrafusp alfa) in combination with IMM27M (Tazebsumab) as a first-line treatment for patients with advanced...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COAL","IBBJ","01541","MDTX","BK4006","PSYK","BMED","BK1161","HCC","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194851355","title":"ImmuneOnco Initiates Phase II Trial: First Patient Dosed with IMM2510 + IMM27M for Front-Line Advanced HCC Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=1194851355","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194851355?lang=en_us&edition=fundamental","pubTime":"2026-08-27 21:21","pubTimestamp":1787836918,"startTime":"0","endTime":"0","summary":"ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (IMMUNEONCO-B, 01541) has dosed the first patient in its Phase II study evaluating the combination of IMM2510 (palverafusp alfa) and IMM27M...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662108812","title":"ImmuneOnco Doses First Patient in Phase II Trial of Imm2510-Imm27m Combo for First-Line Advanced Liver Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2662108812","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662108812?lang=en_us&edition=fundamental","pubTime":"2026-08-27 21:21","pubTimestamp":1787836874,"startTime":"0","endTime":"0","summary":"ImmuneOnco doses first patient in Phase II trial of IMM2510-IMM27M combo for first-line advanced liver cancerImmuneOnco dosed the first patient in a Phase II study of IMM2510 with IMM27M as first-line","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDLbNw7m4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166965470","title":"IMMUNEONCO-B Surges Over 10% in Afternoon Trade on Strong First-Half Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=1166965470","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166965470?lang=en_us&edition=fundamental","pubTime":"2026-08-27 13:51","pubTimestamp":1787809861,"startTime":"0","endTime":"0","summary":"Shares of IMMUNEONCO-B (01541) rallied sharply during Tuesday afternoon trading, climbing nearly 12% at one point before settling at a 10.27% gain to HK$4.08, with turnover reaching HK$6.239 million....","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187887739","title":"Hong Kong Stock Alert | IMMUNEONCO-B (01541) Surges Nearly 12% as Robust Cash Reserves and Major Clinical Milestones Drive Sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=1187887739","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187887739?lang=en_us&edition=fundamental","pubTime":"2026-08-27 11:00","pubTimestamp":1787799615,"startTime":"0","endTime":"0","summary":"Shares of IMMUNEONCO-B (01541) jumped nearly 12% during Tuesday trading, last up 10.41% at HK$4.085 with turnover reaching HK$3.429 million.The surge follows the company's interim results released on...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","MDTX","01541","VXUS","IBBJ","BMED","PSYK","BK4585","BK1161","KCAI","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152821983","title":"IMMUNEONCO-B Reports Interim Results with RMB 25.4 Million Revenue and Key Clinical Trial Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=1152821983","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152821983?lang=en_us&edition=fundamental","pubTime":"2026-08-26 21:56","pubTimestamp":1787752576,"startTime":"0","endTime":"0","summary":"IMMUNEONCO-B (01541) has released its interim results for the six months ended June 30, 2026, reporting revenue of RMB 25.424 million. Research and development expenses totaled RMB 155 million,...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541","IBBQ","BMED","PSYK","BK1161","MDTX","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662708712","title":"ImmuneOnco FY26 Interim Revenue Falls 33.2% to RMB 25.4 Million; R&D Expenses Drop 7.9% to RMB 154.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662708712","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662708712?lang=en_us&edition=fundamental","pubTime":"2026-08-26 21:41","pubTimestamp":1787751717,"startTime":"0","endTime":"0","summary":"ImmuneOnco FY26 interim revenue falls 33.2% to RMB 25.4 million; R&D expenses drop 7.9% to RMB 154.8 millionImmuneOnco posted revenue of RMB 25.4 million for the six months ended June 30, 2026, down 3","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL2N6WK0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118698746","title":"ImmuneOnco reaches two clinical milestones for IMC-003: first PAH patient dosed and Phase I enrolment completed","url":"https://stock-news.laohu8.com/highlight/detail?id=1118698746","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118698746?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:47","pubTimestamp":1787654850,"startTime":"0","endTime":"0","summary":"ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (IMMUNEONCO-B, 01541) has reported two key advances for its independently developed activin receptor type IIA-Fc fusion protein, IMC-003/IMM72. The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192850803","title":"IMMUNEONCO-B (01541) Achieves Two Key Clinical Milestones in IMC-003 Development, Including First PAH Patient Dosed","url":"https://stock-news.laohu8.com/highlight/detail?id=1192850803","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192850803?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:44","pubTimestamp":1787654653,"startTime":"0","endTime":"0","summary":"IMMUNEONCO-B (01541) has announced two significant clinical milestones for IMC-003/IMM72, a proprietary ActRIIA-Fc fusion protein developed by its subsidiary, Immuncare Biopharmaceutical Technology...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMC","01541","BK4168","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662735417","title":"ImmuneOnco Says First PAH Patient Dosed in Phase Ib/IIa Trial of IMC-003","url":"https://stock-news.laohu8.com/highlight/detail?id=2662735417","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662735417?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:37","pubTimestamp":1787654273,"startTime":"0","endTime":"0","summary":"ImmuneOnco says first PAH patient dosed in Phase Ib/IIa trial of IMC-003ImmuneOnco Biopharmaceuticals (Shanghai) dosed the first patient in a Phase Ib/IIa pulmonary arterial hypertension trial of IMC-","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nNDL71fHZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119750546","title":"ImmuneOnco secures FDA IND clearance for Phase Ib/II study of dual-targeting antibody IMM0306 in systemic lupus erythematosus","url":"https://stock-news.laohu8.com/highlight/detail?id=1119750546","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119750546?lang=en_us&edition=fundamental","pubTime":"2026-08-21 20:45","pubTimestamp":1787316325,"startTime":"0","endTime":"0","summary":"Hong Kong-listed ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (IMMUNEONCO-B, 01541) reported that the U.S. Food and Drug Administration has cleared the Investigational New Drug application for...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661260429","title":"ImmuneOnco Wins FDA IND Clearance for Imm0306 Lupus Phase Ib/II Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2661260429","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661260429?lang=en_us&edition=fundamental","pubTime":"2026-08-21 20:07","pubTimestamp":1787314025,"startTime":"0","endTime":"0","summary":"ImmuneOnco wins FDA IND clearance for IMM0306 lupus Phase Ib/II trialFDA cleared an IND for ImmuneOnco’s IMM0306, enabling a Phase Ib/II trial in systemic lupus erythematosus.IMM0306 is a CD47/CD20 bi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL5c90g0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661260410","title":"ImmuneOnco Biopharmaceuticals (Shanghai) - Receives FDA Approval for Ind Application of Imm0306 for Phase Ib/Ii Sle Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2661260410","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661260410?lang=en_us&edition=fundamental","pubTime":"2026-08-21 20:06","pubTimestamp":1787313984,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nFWN44I0F7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01541","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194284340","title":"ImmuneOnco to Convene 26 Aug 2026 Board Meeting for 1H26 Results and Interim Dividend Deliberation","url":"https://stock-news.laohu8.com/highlight/detail?id=1194284340","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194284340?lang=en_us&edition=fundamental","pubTime":"2026-08-14 16:49","pubTimestamp":1786697340,"startTime":"0","endTime":"0","summary":"ImmuneOnco Biopharmaceuticals (Shanghai) Inc. announced that its board of directors will meet on 26 August 2026. The agenda includes: • Reviewing and approving the interim financial results for the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":110,"code":"91000000","status":"200"}]}}